Search Results 51-60 of 16136 for immunothérapie Bylaska
But, there is fast becoming a fourth option for some types of cancer: immunotherapy, which is a biological therapy where the patient's own immune system is ...
Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...
Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High ...
and Margaret T. Grohne Cancer Immunology and Immunotherapy Program are pursuing cutting-edge research to better understand the interaction between the immune ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to evaluate the safety tolerability, PK, preliminary antitumor activity, and effect of biomarkers of XL092 ...
Mayo Clinic's Clinical Immunology and Immunotherapeutics Program conducts translational research on immune-mediated diseases and cancer immunotherapy.
Rochester, Minn. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and ...
The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune ...
About this study. The purpose of this study is to determine whether an investigational immunotherapy Nivolumab, when combined with Ipilimumab, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.